403 related articles for article (PubMed ID: 2866841)
21. Antiarrhythmic agents for chronic ventricular arrhythmias.
Nestico PF; Morganroth J
Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics of the newer antiarrhythmic agents.
Gillis AM; Kates RE
Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
[TBL] [Abstract][Full Text] [Related]
23. New drugs for treatment of ventricular arrhythmias.
Heger JJ; Prystowsky EN; Zipes DP
Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
[TBL] [Abstract][Full Text] [Related]
24. Therapy with investigational antiarrhythmic drugs.
Mead RH; Harrison DC
Med Clin North Am; 1984 Sep; 68(5):1321-37. PubMed ID: 6436596
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of antiarrhythmic drugs.
Block PJ; Winkle RA
Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278
[TBL] [Abstract][Full Text] [Related]
26. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Podrid PJ
Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
[No Abstract] [Full Text] [Related]
27. New drugs for treating cardiac arrhythmias.
Benchimol A; Desser KB
Postgrad Med; 1981 Jan; 69(1):77-84. PubMed ID: 6780988
[TBL] [Abstract][Full Text] [Related]
28. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Kreeger RW; Hammill SC
Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
[TBL] [Abstract][Full Text] [Related]
29. [Drug therapy of tachyarrhythmias (author's transl)].
Theisen K
Klin Wochenschr; 1978 Feb; 56(4):153-68. PubMed ID: 24134
[No Abstract] [Full Text] [Related]
30. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Singh BN; Cho YW; Kuemmerle HP
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
[No Abstract] [Full Text] [Related]
31. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.
Zipes DP; Troup PJ
Am J Cardiol; 1978 May; 41(6):1005-24. PubMed ID: 352121
[TBL] [Abstract][Full Text] [Related]
32. The treatment of ventricular rhythm disturbances.
Somberg JC; Miura D; Keefe DL
Am Heart J; 1986 Jun; 111(6):1162-76. PubMed ID: 2424297
[No Abstract] [Full Text] [Related]
33. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Hellestrand KJ
Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
[No Abstract] [Full Text] [Related]
34. Clinical pharmacokinetics of antiarrhythmic drugs.
Harrison DC; Meffin PJ; Winkle RA
Prog Cardiovasc Dis; 1977; 20(3):217-42. PubMed ID: 335439
[No Abstract] [Full Text] [Related]
35. Worsening of arrhythmias during pharmacological treatment.
Furlanello F; Gramegna L; Dal Forno P; Vergara G; Bettini R; Inama G; Disertori M
G Ital Cardiol; 1984 Oct; 14(10):798-803. PubMed ID: 6440827
[TBL] [Abstract][Full Text] [Related]
36. Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Anderson JL; Harrison DC; Meffin PJ; Winkle RA
Drugs; 1978 Apr; 15(4):271-309. PubMed ID: 648399
[No Abstract] [Full Text] [Related]
37. Electropharmacology of antiarrhythmic drugs.
Rosen MR; Wit AL
Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
[TBL] [Abstract][Full Text] [Related]
38. [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Schmitz W
Klin Wochenschr; 1980 Sep; 58(18):907-18. PubMed ID: 6110804
[TBL] [Abstract][Full Text] [Related]
39. [Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
Atarashi H; Hayakawa H
Nihon Rinsho; 1985 Nov; 43(11):2422-7. PubMed ID: 3936948
[No Abstract] [Full Text] [Related]
40. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Anderson JL
Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
